Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: A Children's Oncology Group study

Blood

Volumn 119, Issue 8, 2012, Pages 1872-1881

  Kang, Huining ^a   Wilson, Carla S ^a   Harvey, Richard C ^a   Chen, I Ming ^a,b   Murphy, Maurice H ^a   Atlas, Susan R ^a   Bedrick, Edward J ^a   Devidas, Meenakshi ^b,c   Carroll, Andrew J ^b,d   Robinson, Blaine W ^e   Stam, Ronald W ^f   Valsecchi, Maria G ^g   Pieters, Rob ^f   Heerema, Nyla A ^b,h   Hilden, Joanne M ^b,i   Felix, Carolyn A ^b,e,j   Reaman, Gregory H ^b,k   Camitta, Bruce ^b,l   Winick, Naomi ^b,m   Carroll, William L ^b,n   Dreyer, ZoAnn E ^b,o   Hunger, Stephen P ^b,i   Willman, Cheryl L ^a,b   more..

^a UNIVERSITY OF NEW MEXICO   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ Children's Hospital Colorado   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^l MEDICAL COLLEGE OF WISCONSIN   (United States)

^m UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁿ NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^o TEXAS CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPS8 GENE; EVENT FREE SURVIVAL; GENE; GENE EXPRESSION PROFILING; HUMAN; INFANT; INFANT DISEASE; IRX2 GENE; MAJOR CLINICAL STUDY; NEGR1 GENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; TACC2 GENE; TPD52 GENE;

EID: 84857554709     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-382861     Document Type: Article

References (46)

1. Pieters R, Schrappe M, De Lorenzo P, et al. Atreatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240-250. (Pubitemid 47082422)
2. Hilden JM, Dinndorf PA, Meerbaum SO, et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006;108(2):441-451. (Pubitemid 44061340)
3. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7(11):823-833. (Pubitemid 350006257)
4. Bardini M, Spinelli R, Bungaro S, et al. DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4. Leukemia. 2010;24(1): 169-176.
5. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A. 1997;94(25):13950-13954. (Pubitemid 28009690)
6. Bardini M, Galbiati M, Lettieri A, et al. Implementation of array based whole-genome highresolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients. Leukemia. 2011; 25(1):175-178.
7. Mohan M, Lin C, Guest E, Shilatifard A. Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nat Rev Cancer. 2010; 10(10):721-728.
8. Stam RW, Schneider P, Hagelstein JA, et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood. 2010; 115(14):2835-2844.
9. Stumpel DJ, Schneider P, van Roon EH, et al. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood. 2009; 114(27):5490-5498.
10. Krivtsov AV, Feng Z, Lemieux ME, et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell. 2008;14(5): 355-368.
11. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-764. (Pubitemid 46582031)
12. Schafer E, Irizarry R, Negi S, et al. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting. Blood. 2010;115(23):4798-4809.
13. Stumpel DJ, Schotte D, Lange-Turenhout EA, et al. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia. 2011;25:429-439
14. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203. (Pubitemid 43292563)
15. Dreyer ZE, Dinndorf P, Joanne HM, et al. Unexpected toxicity with intensified induction in infant acute lymphoid leukemia. ASH Ann Meet Abstr. 2007;110(11):852.
16. Robinson BW, Felix CA. Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences. Methods Mol Biol. 2009;538:85-114.
17. Kang H, Chen IM, Wilson CS, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010; 115(7):1394-1405.
18. Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric highrisk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010; 116(23):4874-4884.
19. MacDonald JW, Ghosh D. COPA-cancer outlier profile analysis. Bioinformatics. 2006;22(23): 2950-2951.
20. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116-5121. (Pubitemid 32397092)
21. Bair E, Hastie T, Paul D, Tibshirani R. Prediction by supervised principal components. J Am Stat Assoc. 2006;101(473):119-137. (Pubitemid 43500030)
22. Breiman L. Classification and Regression Trees. Belmont, CA: Wadsworth International Group; 1984.
23. Trentin L, Giordan M, Dingermann T, Basso G, Te Kronnie G, Marschalek R. Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients. Eur J Haematol. 2009; 83(5):406-419.
24. Gomes AQ, Correia DV, Grosso AR, et al. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells. Haematologica. 2010;95(8): 1397-1404.
25. Kzhyshkowska J. Multifunctional receptor stabilin-1 in homeostasis and disease. Scientific-World J. 2010;10:2039-2053.
26. Stam RW, Schneider P, de Lorenzo P, Valsecchi MG, den Boer ML, Pieters R. Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia. Blood. 2007; 110(7):2774-2775. (Pubitemid 47523212)
27. Ono R, Kumagai H, Nakajima H, et al. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation. Leukemia. 2009;23(12):2197-2209.
28. Abu-Farha M, Lambert JP, Al-Madhoun AS, Elisma F, Skerjanc IS, Figeys D. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics. 2008;7(3):560-572. (Pubitemid 351472465)
29. Dou Z, Ding X, Zereshki A, et al. TTK kinase is essential for the centrosomal localization of TACC2. FEBS Lett. 2004;572(1-3):51-56. (Pubitemid 39092512)
30. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer. 2004; 4(2):133-142.
31. Bürglin TR. Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel domain conserved between plants and animals. Nucleic Acids Res. 1997; 25(21):4173-4180. (Pubitemid 27485191)
32. Baird DM. Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med. 2010;12:e16.
33. Guo X, Liu W, Pan Y, et al. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene. 2010;29(27):3908-3920.
34. Kamalakaran S, Varadan V, Giercksky Russnes HE, et al. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Mol Oncol. 2011;5(1):77-92.
35. Gessner A, Thomas M, Castro PG, et al. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT. Leukemia. 2010;24(10):1751-1759.
36. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102(7):2321-2333. (Pubitemid 37193565)
37. Bashir M, Kirmani D, Bhat HF, et al. P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Cell Commun Signal. 2010;8:13.
38. Chen H, Wu X, Pan ZK, Huang S. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. Cancer Res. 2010;70(23): 9979-9990.
39. Barbaric D, Byth K, Dalla-Pozza L, Byrne JA. Expression of tumor protein D52-like genes in childhood leukemia at diagnosis: clinical and sample considerations. Leuk Res. 2006;30(11):1355-1363. (Pubitemid 44307322)
40. Shehata M, Weidenhofer J, Thamotharampillai K, Hardy JR, Byrne JA. Tumor protein D52 over-expression and gene amplification in cancers from a mosaic of microarrays. Crit Rev Oncog. 2008;14(1):33-55.
41. Hosking FJ, Leslie S, Dilthey A, et al. MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia. Blood. 2011;117(5): 1633-1640.
42. Ntougkos E, Rush R, Scott D, et al. The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates. Clin Cancer Res. 2005;11(16):5764-5768. (Pubitemid 41170301)
43. Jansen MW, Corral L, van der Velden VH, et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia. 2007;21(4):633-641. (Pubitemid 46444545)
44. Ucisik-Akkaya E, Davis CF, Gorodezky C, Alaez C, Dorak MT. HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility. Cell Stress Chaperones. 2010;15(5):475-485.
45. Shahzad MM, Arevalo JM, Armaiz-Pena GN, et al. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem. 2010;285(46):35462-35470.
46. Snoussi K, Mahfoudh W, Bouaouina N, et al. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer. 2010;10:283.